Skip to main content
SpringerLink
Log in

COVID-19 Vaccination in Persons with Diabetes: How they Work

  • Chapter
  • First Online:
Diabetes and COVID-19

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Coronavirus disease 2019 (COVID-19) is now recognized to be a highly prevalent endemic viral illness, with diabetes associated with increased likelihood of severe infection and mortality. We have reviewed the associations of diabetes with immune response to COVID-19 itself and to the COVID-19 vaccine, as well as discussed the existing evidence of the efficacy of the vaccine in persons with diabetes. Immunity to vaccination appears to decline more rapidly in patients with diabetes than in persons without diabetes, and the existing evidence suggests COVID-19 vaccination to be safe in patients with diabetes, leading us to conclude that patients with diabetes should be prioritized for vaccination and for booster doses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nassar M, Nso N, Alfishawy M, Novikov A, Yaghi S, Medina L, Toz B, Lakhdar S, Idrees Z, Kim Y, Gurung DO, Siddiqui RS, Zheng D, Agladze M, Sumbly V, Sandhu J, Castillo FC, Chowdhury N, Kondaveeti R, Bhuiyan S, Perez LG, Ranat R, Gonzalez C, Bhangoo H, Williams J, Osman AE, Kong J, Ariyaratnam J, Mohamed M, Omran I, Lopez M, Nyabera A, Landry I, Iqbal S, Gondal AZ, Hassan S, Daoud A, Baraka B, Trandafirescu T, Rizzo V. Current systematic reviews and meta-analyses of COVID-19. World J Virol. 2021;10:182–208. https://doi.org/10.5501/wjv.v10.i4.182.

    Article  PubMed  PubMed Central  Google Scholar 

  2. COVID-19 coronavirus pandemic. 2021. https://www.worldometers.info/coronavirus/. Accessed 29 Dec 2021.

  3. Ali H, Alterki A, Sindhu S, Alahmad B, Hammad M, Al-Sabah S, Alghounaim M, Jamal MH, Aldei A, Mairza MJ, Husain M, Deverajan S, Ahmad R, Cherian P, Alkhairi I, Alkandari A, Abubaker J, Abu-Farha M, Al-Mulla F. Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination. Front Immunol. 2021;12:752233. https://doi.org/10.3389/fimmu.2021.752233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pal R, Bhadada SK, Misra A. COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges. Diabetes Metab Syndr. 2021;15:505–8. https://doi.org/10.1016/j.dsx.2021.02.026.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, Xu J, Wu F, Duan L, Yin Z, Luo H, Xiong N, Xu M, Zeng T, Jin Y. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020;63:2102–11. https://doi.org/10.1007/s00125-020-05209-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huang Y, Guo H, Zhou Y, Guo J, Wang T, Zhao X, Li H, Sun Y, Bian X, Fang C. The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes. Diabetes Res Clin Pract. 2020;169:108448. https://doi.org/10.1016/j.diabres.2020.108448.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Driggin E, Maddox TM, Ferdinand KC, Kirkpatrick JN, Ky B, Morris AA, Mullen JB, Parikh SA, Philbin DM Jr, Vaduganathan M. ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77:1938–48. https://doi.org/10.1016/j.jacc.2021.02.017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lumeng CN. Innate immune activation in obesity. Mol Aspects Med. 2013;34:12–29. https://doi.org/10.1016/j.mam.2012.10.002.

    Article  CAS  PubMed  Google Scholar 

  9. Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of diabetes in patients diagnosed with COVID-19. Front Immunol. 2020;11:576818. https://doi.org/10.3389/fimmu.2020.576818.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, Nyein A, Mohamed M, Alqassieh A, Soliman K, Alfishawy M, Sachmechi I, Misra A. Diabetes mellitus and COVID-19: review article. Diabetes Metab Syndr. 2021;15:102268. https://doi.org/10.1016/j.dsx.2021.102268.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pal R, Sachdeva N, Mukherjee S, Suri V, Zohmangaihi D, Ram S, Puri GD, Bhalla A, Soni SL, Pandey N, Bhansali A, Bhadada SK. Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: a preliminary report. Diabetes Metab Syndr. 2021;15:193–6. https://doi.org/10.1016/j.dsx.2020.12.035.

    Article  CAS  PubMed  Google Scholar 

  12. Singh AK, Phatak SR, Singh R, Bhattacharjee K, Singh NK, Gupta A, Sharma A. Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: the final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study. Vaccine. 2021;39:6492–509. https://doi.org/10.1016/j.vaccine.2021.09.055.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Al-Suhaimi EA, Shehzad A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res. 2013;18:12. https://doi.org/10.1186/2047-783X-18-12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Guest CB, Park MJ, Johnson DR, Freund GG. The implication of proinflammatory cytokines in type 2 diabetes. Front Biosci. 2008;13:5187–94. https://doi.org/10.2741/3074.

    Article  CAS  PubMed  Google Scholar 

  15. Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: The current evidence and treatment strategies. Front Immunol. 2020;11:1708. https://doi.org/10.3389/fimmu.2020.01708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Vaccines candidates in clinical trials. 2021. https://covid19.trackvaccines.org/vaccines/#approved. Accessed 19 Nov 2021.

  17. He X, Hong W, Pan X, Lu G, Wei X. SARS-CoV-2 omicron variant: characteristics and prevention. MedComm. 2020;2:838–45. https://doi.org/10.1002/mco2.110.

    Article  CAS  Google Scholar 

  18. Okamura S, Ebina H. Could live attenuated vaccines better control COVID-19? Vaccine. 2021;39:5719–26. https://doi.org/10.1016/j.vaccine.2021.08.018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dunkle LM, Kotloff KL, Gay CL, Anez G, Adelglass JM, Barrat Hernandez AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruiz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F, 2019nCoV-301 Study Group. Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico. N Engl J Med. 2021; https://doi.org/10.1056/NEJMoa2116185.

  20. Overview of COVID-19 vaccines. 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-COVID-19-vaccines.html. Accessed 10 Oct 2022.

  21. Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021;14:3459–76. https://doi.org/10.2147/IDR.S315727.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tanriover MD, Doganay HL, Akova M, Guner HR, Azap A, Akhan S, Kose S, Erdinc FS, Akalin EH, Tabak OF, Pullukcu H, Batum O, Simsek Yavuz S, Turhan O, Yildirmak MT, Koksal I, Tasova Y, Korten V, Yilmaz G, Celen MK, Altin S, Celik I, Bayindir Y, Karaoglan I, Yilmaz A, Ozkul A, Gur H, Unal S, CoronaVac Study Group. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398:213–22. https://doi.org/10.1016/S0140-6736(21)01429-X.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Vasireddy D, Vanaparthy R, Mohan G, Malayala SV, Atluri P. Review of COVID-19 variants and COVID-19 vaccine efficacy: what the clinician should know? J Clin Med Res. 2021;13:317–25. https://doi.org/10.14740/jocmr4518.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK phase 3 trial. 2021. https://ir.novavax.com/2021-01-28-Novavax-COVID-19-Vaccine-Demonstrates-89-3-Efficacy-in-UK-Phase-3-Trial. Accessed 10 Oct 2022.

  25. Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, Blane B, Bonsall D, Cicconi P, Charlton S, Clutterbuck EA, Collins AM, Cox T, Darton TC, Dold C, Douglas AD, CJA D, Ewer KJ, Flaxman AL, Faust SN, Ferreira DM, Feng S, Finn A, Folegatti PM, Fuskova M, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hallis B, Heath PT, Hay J, Hill HC, Jenkin D, Kerridge S, Lazarus R, Libri V, Lillie PJ, Ludden C, Marchevsky NG, Minassian AM, McGregor AC, Mujadidi YF, Phillips DJ, Plested E, Pollock KM, Robinson H, Smith A, Song R, Snape MD, Sutherland RK, Thomson EC, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Williams CJ, Hill AVS, Lambe T, Gilbert SC, Voysey M, Ramasamy MN, Pollard AJ, COVID-19 Genomics UK consortium; AMPHEUS Project; Oxford COVID-19 Vaccine Trial Group. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021;397:1351–62. https://doi.org/10.1016/S0140-6736(21)00628-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Di Valerio Z, La Fauci G, Solda G, Montalti M, Lenzi J, Forcellini M, Barvas E, Guttmann S, Poluzzi E, Raschi E, Riccardi R, Fantini MP, Salussolia A, Gori D. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance. EClinicalMedicine. 2022;49:101468. https://doi.org/10.1016/j.eclinm.2022.101468.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hansen CH, Michlmayr D, Gubbels SM, Mølbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397:1204–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kojima N, Shrestha NK, Klausner JD. A systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection. Eval Health Prof. 2021;44:327–32. https://doi.org/10.1177/01632787211047932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Soetedjo NNM, Iryaningrum MR, Lawrensia S, Permana H. Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: a systematic review. Diabetes Metab Syndr. 2022;16:102406. https://doi.org/10.1016/j.dsx.2022.102406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nassar M, Nso N, Gonzalez C, Lakhdar S, Alshamam M, Elshafey M, Abdalazeem Y, Nyein A, Punzalan B, Durrance RJ, Alfishawy M, Bakshi S, Rizzo V. COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes Metab Syndr. 2021;15:102205. https://doi.org/10.1016/j.dsx.2021.102205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Liu BD, Ugolini C, Jha P. Two cases of post-moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus. Cureus. 2021;13:e16172. https://doi.org/10.7759/cureus.16172.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre Syndrome following Pfizer COVID-19 vaccine. Cureus. 2021;13:e13426. https://doi.org/10.7759/cureus.13426.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kong J, Cuevas-Castillo F, Nassar M, Lei CM, Idrees Z, Fix WC, Halverstam C, Mir A, Elbendary A, Mathew A. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: case report. J Infect Public Health. 2021;14:1392–4. https://doi.org/10.1016/j.jiph.2021.06.021.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Nassar M, Chung H, Dhayaparan Y, Nyein A, Acevedo BJ, Chicos C, Zheng D, Barras M, Mohamed M, Alfishawy M, Nso N, Rizzo V, Kimball E. COVID-19 vaccine induced rhabdomyolysis: case report with literature review. Diabetes Metab Syndr. 2021;15:102170. https://doi.org/10.1016/j.dsx.2021.06.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Alfishawy M, Nassar M, Mohamed M, Fatthy M, Elmessiery RM. New-onset type 1 diabetes mellitus with diabetic ketoacidosis and pancreatitis in a patient with COVID-19. Sci Afr. 2021;13:e00915. https://doi.org/10.1016/j.sciaf.2021.e00915.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Alhumaid S, Al Mutair A, Al Alawi Z, Rabaan AA, Alomari MA, Al Salman SA, Al-Alawi AS, Al Hassan MH, Alhamad H, Al-Kamees MA, Almousa FM, Mufti HN, Alwesabai AM, Dhama K, Al-Tawfiq JA, Al-Omari A. Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13:120. https://doi.org/10.1186/s13098-021-00740-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Heald AH, Stedman M, Horne L, Rea R, Whyte M, Gibson JM, Anderson SG, Ollier W. The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes. Diabet Med. 2021:e14774. https://doi.org/10.1111/dme.14774.

  38. Lee HJ, Sajan A, Tomer Y. Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion. J Endocr Soc. 2021;5:bvab141. https://doi.org/10.1210/jendso/bvab141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Ganakumar V, Jethwani P, Roy A, Shukla R, Mittal M, Garg MK. Diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) temporally related to COVID-19 vaccination. Diabetes Metab Syndr. 2022;16:102371. https://doi.org/10.1016/j.dsx.2021.102371.

    Article  CAS  PubMed  Google Scholar 

  40. Edwards AE, Vathenen R, Henson SM, Finer S, Gunganah K. Acute hyperglycaemic crisis after vaccination against COVID-19: a case series. Diabet Med. 2021;38:e14631. https://doi.org/10.1111/dme.14631.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Mishra A, Ghosh A, Dutta K, Tyagi K, Misra A. Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: report of three cases. Diabetes Metab Syndr. 2021;15:102151. https://doi.org/10.1016/j.dsx.2021.05.024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Diabetes & COVID-19 Vaccination and treatments. 07 Dec 2021. https://idf.org/our-network/regions-members/europe/europe-news/370-diabetes-coronavirus-vaccination.html. Accessed 1 Aug 2022, 2021.

  43. Marfella R, D’Onofrio N, Sardu C, Scisciola L, Maggi P, Coppola N, Romano C, Messina V, Turriziani F, Siniscalchi M, Maniscalco M, Boccalatte M, Napolitano G, Salemme L, Marfella LV, Basile E, Montemurro MV, Papa C, Frascaria F, Papa A, Russo F, Tirino V, Papaccio G, Galdiero M, Sasso FC, Barbieri M, Rizzo MR, Balestrieri ML, Angelillo IF, Napoli C, Paolisso G. Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes Obes Metab. 2022;24:160–65.

    Google Scholar 

  44. Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, Minassian AM, Cho I, Kumar L, Plested JS, Rivers EJ, Robertson A, Dubovsky F, Glenn G, Heath PT, 2019nCoV-302 Study Group. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021; https://doi.org/10.1016/S2213-2600(21)00409-4.

  45. Interim guidance for routine and influenza immunization services during the COVID-19 pandemic. 2021. https://www.cdc.gov/vaccines/pandemic-guidance/index.html. Accessed 29 May 2022.

  46. Administer the vaccine(s). 2021. https://www.cdc.gov/vaccines/hcp/admin/administer-vaccines.html#covid19-with-other-vaccines. Accessed 10 Oct 2022.

  47. COVID-19 Vaccine Implementation in Pediatric Practices. Accessed: 3/26/2023, 2023. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/covid-19-vaccine-for-children/covid-19-vaccine-implementation-in-pediatric-practices/.

  48. Dooling K, Marin M, Wallace M, McClung N, Chamberland M, Lee GM, Talbot HK, Romero JR, Bell BP, Oliver SE. The advisory Committee on Immunization practices’ updated interim recommendation for allocation of COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69:1657–60. https://doi.org/10.15585/mmwr.mm695152e2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, Cravioto A, Rees H, Higgins JPT, Boutron I, Pan H, Gruber MF, Arora N, Kazi F, Gaspar R, Swaminathan S, Ryan MJ, Henao-Restrepo AM. Considerations in boosting COVID-19 vaccine immune responses. Lancet. 2021;398:1377–80. https://doi.org/10.1016/S0140-6736(21)02046-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Munro AP, Feng S, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Lancet Infect Dis. 2022;22:1131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. CDC recommends the first updated COVID-19 booster. 2022. https://www.cdc.gov/media/releases/2022/s0901-covid-19-booster.html. Accessed 10 Oct 2022.

  52. CDC expands booster shot eligibility and strengthens recommendations for 12–17 year olds. 2022. https://www.cdc.gov/media/releases/2022/s0105-Booster-Shot.html. Accessed 9 Jan 2022.

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Icahn School of Medicine at Mount Sinai/NYC Health + Hospitals, Queens, NY, USA

    Mahmoud Nassar

  2. Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Diabetes Foundation (India), National Diabetes Obesity and Cholesterol Foundation (NDOC), New Delhi, India

    Anoop Misra

  3. Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Zachary Bloomgarden

Authors
  1. Mahmoud Nassar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anoop Misra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zachary Bloomgarden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahmoud Nassar .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY, USA

    Alyson K. Myers

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nassar, M., Misra, A., Bloomgarden, Z. (2023). COVID-19 Vaccination in Persons with Diabetes: How they Work. In: Myers, A.K. (eds) Diabetes and COVID-19. Contemporary Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-031-28536-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-28536-3_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-28535-6

  • Online ISBN: 978-3-031-28536-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation